08/14/2025
4:07 PM | Lipella Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/25/2025
2:14 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2025
3:25 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2025
4:05 PM | Lipella Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/01/2025
8:19 PM | Huang Leaf (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
04/14/2025
5:08 AM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2025
7:39 PM | Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
04/09/2025
7:43 PM | Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
04/09/2025
4:06 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/07/2025
6:16 PM | Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/07/2025
6:20 PM | Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
Get the Latest News and Ratings for LIPO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Lipella Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
04/07/2025
5:05 AM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2025
4:14 PM | Lipella Pharmaceuticals (Filer)
| Form 424B5 | |
04/03/2025
11:15 PM | Lipella Pharmaceuticals (Filer)
| Form EFFECT | |
03/28/2025
5:21 AM | Lipella Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/27/2025
6:56 PM | Lipella Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/19/2025
5:23 PM | Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
03/18/2025
4:01 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/17/2025
7:18 PM | Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
03/17/2025
7:12 PM | Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:01 PM | Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:09 PM | Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
03/11/2025
4:26 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/24/2025
3:05 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/11/2025
8:28 AM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/10/2025
4:32 PM | Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
02/10/2025
4:35 PM | Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
01/30/2025
4:27 PM | Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
01/30/2025
4:28 PM | Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
01/23/2025
5:08 PM | Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
01/23/2025
5:11 PM | Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
01/17/2025
7:13 PM | Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
7:17 PM | Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
01/16/2025
5:51 AM | Lipella Pharmaceuticals (Filer)
| Form 424B3 | |
01/15/2025
11:15 PM | Lipella Pharmaceuticals (Filer)
| Form EFFECT | |
01/13/2025
7:42 AM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
4:25 PM | Lipella Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/07/2025
4:28 PM | Lipella Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
01/06/2025
4:25 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2025
8:22 PM | Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
8:25 PM | Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
When the levee breaks (Ad) The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was projected. According to Porter Stansberry, this is panic-level borrowing… and a clear sign we’re nearing America’s financial breaking point.
In his latest emergency briefing, Porter outlines why the cracks in our system are widening fast—and how Trump’s policies may be accelerating the collapse. More importantly, he reveals three moves you can make now to protect and potentially grow your wealth before the levee breaks. Click here to watch the urgent broadcast and get ahead of what’s coming. |
12/30/2024
3:11 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2024
8:28 PM | Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
8:31 PM | Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
12/27/2024
3:05 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2024
8:29 AM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
4:26 PM | Lipella Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
4:01 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2024
4:24 PM | Lipella Pharmaceuticals (Filer)
| Form PRE 14A | |
11/01/2024
4:00 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2024
3:05 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
4:00 PM | Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SC 13D/A | |
10/17/2024
4:00 PM | Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SC 13D/A | |
09/11/2024
4:10 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2024
3:05 PM | Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SC 13D/A | |
MarketBeat All Access